It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Exposure to microgravity affects human physiology in various ways, and astronauts frequently report skin-related problems. Skin rash and irritation are frequent complaints during space missions, and skin thinning has also been reported after returning to Earth. However, spaceflight missions for studying the physiological changes in microgravity are impractical. Thus, we used a previously developed 3D clinostat to simulate a microgravity environment and investigate whether physiological changes of the skin can be reproduced in a 3D in vitro setting. Our results showed that under time-averaged simulated microgravity (taSMG), the thickness of the endothelial cell arrangement increased by up to 59.75%, indicating skin irritation due to vasodilation, and that the diameter of keratinocytes and fibroblast co-cultured spheroids decreased by 6.66%, representing skin thinning. The α1 chain of type I collagen was upregulated, while the connective tissue growth factor was downregulated under taSMG. Cytokeratin-10 expression was significantly increased in the taSMG environment. The clinostat-based 3D culture system can reproduce physiological changes in the skin similar to those under microgravity, providing insight for understanding the effects of microgravity on human health before space exploration.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Seoul National University College of Medicine, Department of Biomedical Engineering, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Seoul National University Hospital, Department of Emergency Medicine, Seoul National University College of Medicine, Seoul, Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X)
2 Interdisciplinary Program in Bioengineering, Graduate School, Seoul National University, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
3 Seoul National University College of Medicine, Department of Biomedical Engineering, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
4 Seoul National University College of Medicine, Department of Dermatology, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Institute of Human-Environment Interface Biology, Seoul National University, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
5 Seoul National University College of Medicine, Department of Pharmacology and Biomedical Sciences, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
6 Seoul National University College of Medicine, Department of Surgery, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
7 Seoul National University College of Medicine, Department of Biomedical Engineering, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Institute of Bioengineering, Seoul National University, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)